<DOC>
	<DOCNO>NCT01160432</DOCNO>
	<brief_summary>The aim study examine tolerability abuse potential dilute methadone solution ( 5 mg/ml â†’ 2 mg/ml ) combination naloxone opioid substitution treatment . Study hypothesis : Treatment diluted combination product safer methadone alone ( 5 mg/ml ) combination product precipitate withdrawal symptom opioid dependent patient .</brief_summary>
	<brief_title>Naloxone Methadone Combination ( NAMEKO )</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>opioid dependence methadone treatment change methadone dose last 10 day good treatment compliance accord doctor normal ALAT AFOS value ( increase double normal level ) severe renal hepatic failure acute psychosis age 18 pregnancy legal incompetence severe somatic disease chaotic situation life medication disease contraindication study treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>opiate dependence</keyword>
	<keyword>methadone</keyword>
	<keyword>naloxone</keyword>
	<keyword>withdrawal symptom</keyword>
	<keyword>substitution treatment</keyword>
</DOC>